CXL01B13 | 非尔氨酯 | felbamate | Active ingredient | Chemical Drugs(2) | New Drug Application | 2001-10-24 | 北京昭衍新药研究中心 | Joinn Laboratories (Beijing) | Approval Completed-Pending Certificated | | view |
CXL01807 | 地洛他定片 | desloratadine | Tablet | Chemical Drugs(2) | New Drug Application | 2001-08-28 | 北京昭衍新药研究中心 | Joinn Laboratories (Beijing) | | | view |
CXL01806 | 地洛他定 | desloratadine | Active ingredient | Chemical Drugs(2) | New Drug Application | 2001-08-28 | 北京昭衍新药研究中心 | Joinn Laboratories (Beijing) | Approval Completed-Pending Certificated | | view |
CXL01B14 | 非尔氨酯片 | felbamate | Tablet | Chemical Drugs(2) | New Drug Application | 2001-10-24 | 北京昭衍新药研究中心 | Joinn Laboratories (Beijing) | In Review | 2001-10-23 | view |
CXS00407 | 盐酸川芎嗪氯化钠注射液 | Ligustrazine Hydrochloride | Injection | Chemical Drugs(4) | New Drug Application | 2000-12-08 | 北京昭衍新药研究中心 吉林省四平巨能药业有限公司 | | Certificate Issued | 2001-10-31 | view |
CXL20020357 | 盐酸二甲双胍缓释片 | metformin hydrochloride | Tablet, extended release | Chemical Drugs(4) | New Drug Application | 2002-03-07 | 北京昭衍新药研究中心 | Joinn Laboratories (Beijing) | Approval Completed-Pending Certificated | 2002-12-04 | view |
CXL01963 | 盐酸氮卓斯汀滴眼液 | azelastine hydrochloride | Eye drops | Chemical Drugs(2) | New Drug Application | 2001-10-19 | 北京昭衍新药研究中心 | Joinn Laboratories (Beijing) | Approval Completed-Pending Certificated | 2003-01-22 | view |
CXL01936 | 醋酸奥曲肽 | Octreotide acetate | Active ingredient | Chemical Drugs(4) | New Drug Application | 2001-10-19 | 北京昭衍新药研究中心 | Joinn Laboratories (Beijing) | Approval Completed-Pending Certificated | 2003-04-02 | view |
CXL01937 | 醋酸奥曲肽注射液 | Octreotide acetate | Injection | Chemical Drugs(4) | New Drug Application | 2001-10-19 | 北京昭衍新药研究中心 | Joinn Laboratories (Beijing) | Approval Completed-Pending Certificated | 2003-04-02 | view |
CXL01A33G | 盐酸奈法唑酮 | nefazodone hydrochloride | Active ingredient | Chemical Drugs(2) | New Drug Application | 2002-01-15 | 北京昭衍新药研究中心 | Joinn Laboratories (Beijing) | Approval Completed-Pending Certificated | 2003-04-03 | view |
CXL01A34G | 盐酸奈法唑酮片 | nefazodone hydrochloride | Tablet | Chemical Drugs(2) | New Drug Application | 2002-01-15 | 北京昭衍新药研究中心 | Joinn Laboratories (Beijing) | Approval Completed-Pending Certificated | 2003-04-03 | view |
CXL01D43 | 佐米曲普坦 | zolmitriptan | Active ingredient | Chemical Drugs(4) | New Drug Application | 2001-11-23 | 北京昭衍新药研究中心 | Joinn Laboratories (Beijing) | Approval Completed-Pending Certificated | 2003-04-07 | view |
CXL20020584 | 齐留通片 | zileuton | Tablet | Chemical Drugs(2) | New Drug Application | 2002-04-01 | 北京昭衍新药研究中心 | Joinn Laboratories (Beijing) | Approval Completed-Pending Certificated | 2003-04-07 | view |
CXL20022070 | 齐留通胶囊 | zileuton | Capsule | Chemical Drugs(2) | New Drug Application | 2002-08-16 | 北京昭衍新药研究中心 | Joinn Laboratories (Beijing) | Approval Completed-Pending Certificated | 2003-04-07 | view |
CXL01D44 | 佐米曲普坦片 | zolmitriptan | Tablet | Chemical Drugs(4) | New Drug Application | 2001-11-23 | 北京昭衍新药研究中心 | Joinn Laboratories (Beijing) | Approval Completed-Pending Certificated | 2003-04-07 | view |
CXL20020583 | 齐留通 | zileuton | Active ingredient | Chemical Drugs(2) | New Drug Application | 2002-04-01 | 北京昭衍新药研究中心 | Joinn Laboratories (Beijing) | Approval Completed-Pending Certificated | 2003-04-07 | view |
CXL01C76G | 盐酸洛美利嗪片 | Lomerizine Hydrochloride | Tablet | Chemical Drugs(2) | New Drug Application | 2001-11-23 | 北京昭衍新药研究中心 | Joinn Laboratories (Beijing) | Certificate Issued | 2003-05-09 | view |
CXL01C75G | 盐酸洛美利嗪 | Lomerizine Hydrochloride | Active ingredient | Chemical Drugs(2) | New Drug Application | 2001-11-23 | 北京昭衍新药研究中心 | Joinn Laboratories (Beijing) | Certificate Issued | 2003-05-09 | view |
CXL20021685 | 聚乙二醇4000散剂 | Macrogol 4000 | Powder | Chemical Drugs(4) | New Drug Application | 2002-07-15 | 北京昭衍新药研究中心 | Joinn Laboratories (Beijing) | Certificate Issued | 2003-05-16 | view |
CXL20021245G | 替米沙坦 | telmisartan | Active ingredient | Chemical Drugs(4) | New Drug Application | 2002-08-13 | 北京昭衍新药研究中心 | Joinn Laboratories (Beijing) | Certificate Issued | 2003-06-20 | view |